Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Work In Process (2016 - 2018)

Sanofi (SNY) has disclosed Work In Process for 4 consecutive years, with $4.7 billion as the latest value for Q4 2018.

  • Quarterly Work In Process rose 7.34% to $4.7 billion in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $4.7 billion through Dec 2018, up 7.34% year-over-year, with the annual reading at $4.7 billion for FY2018, 7.34% up from the prior year.
  • Work In Process hit $4.7 billion in Q4 2018 for Sanofi, up from $4.3 billion in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $4.7 billion in Q4 2018 to a low of $3.8 billion in Q4 2015.
  • Historically, Work In Process has averaged $4.2 billion across 4 years, with a median of $4.2 billion in 2016.
  • Biggest five-year swings in Work In Process: grew 7.56% in 2016 and later grew 5.89% in 2017.
  • Year by year, Work In Process stood at $3.8 billion in 2015, then grew by 7.56% to $4.1 billion in 2016, then increased by 5.89% to $4.3 billion in 2017, then increased by 7.34% to $4.7 billion in 2018.
  • Business Quant data shows Work In Process for SNY at $4.7 billion in Q4 2018, $4.3 billion in Q4 2017, and $4.1 billion in Q4 2016.